Quantity size:
0.2ml
Concentration:
1mg/ml 真核翻译起始因子4E抗体 Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
eIF4E, a protein modulates translation of maternal mRNAs in early embryos before the onset of zygotic transcription. eIF4E also influences the overall rate of translation. eIF4E binds to the 7 methyl GTP cap structure of eukaryotic mRNAs. Phosphorylation of eIF4E on serine 209 regulates the affinity of this protein for the 7 methyl GTP cap and/or RNA.真核翻译起始因子4E抗体 Phosphorylation also enhances the interaction of eIF4E with eIF4G, which form a complex known as eIF4F. eIF4E phosphorylation is correlated with increased translational rate in a number of cell types. Several kinases are currently being investigated as potential regulators of eIF4E including PKC and/or the MAP kinase activated Mnk.
真核翻译起始因子4E抗体Also known as:
EIF4F; eIF-4E; eIF 4E; CBP; eIF 4F 25 kDa subunit; CBP; eIF 4E; eIF 4F 25 kDa subunit; EIF 4F; EIF4E1; EIF4EL1; EIF4F; Eukaryotic Translation Initiation Factor 4 E; Eukaryotic translation initiation factor 4E like 1; Messanger RNA Cap Binding Protein eIF 4E.
Specificity:
●
Rabbit Polyclonal IgG, 真核翻译起始因子4E抗体affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Chicken, Dog, Pig, Cow, Horse, Rabbit, Daniorerio.
●
Immunogen: KLH conjugated synthetic peptide derived from human eIF4E.
●
真核翻译起始因子4E抗体Predicted Molecular Weight: 24kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working dilutions must be determined by the end user.
kl358Hu01凋亡信号调节激酶I(ASK1)多克隆抗体Polyclonal Antibody to Apoptosis Signal Regulating Kinase 1 (ASK1)
kl360Hu01酸性神经鞘磷脂酶(ASM)多克隆抗体Polyclonal Antibody to Acid Sphingomyelinase (ASM)
kl361Hu01毛细血管扩张性共济失调突变因子(ATM)多克隆抗体Polyclonal Antibody to Ataxia Telangiectasia Mutated (ATM)
kl364Hu01乳腺癌易感蛋白2(BRCA2)多克隆抗体Polyclonal Antibody to Breast Cancer Susceptibility Protein 2 (BRCA2)
kl364Mu01乳腺癌易感蛋白2(BRCA2)多克隆抗体Polyclonal Antibody to Breast Cancer Susceptibility Protein 2 (BRCA2)
kl365Hu01葡萄糖激酶调节蛋白(GKRP)多克隆抗体Polyclonal Antibody to Glucokinase Regulatory Protein (GKRP)
kl366Hu01血管内皮钙黏蛋白(CDH5)多克隆抗体Polyclonal Antibody to Cadherin 5 (CDH5)
kl366Mu01血管内皮钙黏蛋白(CDH5)多克隆抗体Polyclonal Antibody to Cadherin 5 (CDH5)
kl367Hu01血管内皮生长因子受体2(VEGFR2)多克隆抗体Polyclonal Antibody to Vascular Endothelial Growth Factor Receptor 2 (VEGFR2)
kl367Mu01血管内皮生长因子受体2(VEGFR2)多克隆抗体Polyclonal Antibody to Vascular Endothelial Growth Factor Receptor 2 (VEGFR2)
kl367Ra01血管内皮生长因子受体2(VEGFR2)多克隆抗体Polyclonal Antibody to Vascular Endothelial Growth Factor Receptor 2 (VEGFR2)
kl368Hu01肝配蛋白A受体1(EPHA1)多克隆抗体Polyclonal Antibody to Ephrin Type A Receptor 1 (EPHA1)
kl370Hu01乳酸脱氢酶A(LDHA)多克隆抗体Polyclonal Antibody to Lactate Dehydrogenase A (LDHA)
kl370Ra01乳酸脱氢酶A(LDHA)多克隆抗体Polyclonal Antibody to Lactate Dehydrogenase A (LDHA)
kl371Hu01转醛缩酶(TALDO1)多克隆抗体Polyclonal Antibody to Transaldolase (TALDO1)
kl371Ra01转醛缩酶(TALDO1)多克隆抗体Polyclonal Antibody to Transaldolase (TALDO1)
kl372Hu01鳞状细胞癌抗原1(SCCA1)多克隆抗体Polyclonal Antibody to Squamous Cell Carcinoma Antigen 1 (SCCA1)
kl373Hu01防御素β1(DEFβ1)多克隆抗体Polyclonal Antibody to Defensin Beta 1 (DEFb1)
kl373Mu01防御素β1(DEFβ1)多克隆抗体Polyclonal Antibody to Defensin Beta 1 (DEFb1)
kl373Po01防御素β1(DEFβ1)多克隆抗体Polyclonal Antibody to Defensin Beta 1 (DEFb1)
kl373Ra01防御素β1(DEFβ1)多克隆抗体Polyclonal Antibody to Defensin Beta 1 (DEFb1)
更多
企业名称
上海康朗生物科技有限公司
企业信息已认证
企业类型
信用代码
310112001510759
成立日期
2015-05-29
注册资本
100
经营范围
从事生物科技技术领域内技术开发、技术咨询、技术服务、技术转让,实验分析仪器、化工产品及原料(除危险化学品、监控化学品、烟花爆竹、民用爆竹物品、易制毒化学品)、仪器仪表、环保设备、酒店用品、皮革制品、床上用品、电子产品的销售。【依法须经批准的项目,经相关部门批准后方可开展经营活动】
上海康朗生物科技有限公司
公司地址
上海市闵行区闵北路88弄1-30号第22栋BV145室
客服电话